In her role as global HEOR project lead Anina develops healtheconomic tools and analyses to facilitate and maintain patient access to new cardiovascular medications. During almost 20 years in the pharmaceutical industry she has worked in several therapy areas such as cardiology, oncology, hemophilia and MS and gained vast experience on the Scandinavian HTA and market access processes. Anina holds a Master's degree in Economical Mathematics from the University of Ulm, Germany. Her special interest is the field of Real World Evidence.